Literature DB >> 11477367

Elevated right ventricular pressures are not a contraindication to liver transplantation in Alagille syndrome.

C Ovaert1, C Germeau, C Barrea, S Moniotte, L Van Obbergh, E Sokal, R Reding, J B Otte, T Sluysmans.   

Abstract

BACKGROUND: Elevated right ventricle pressure resulting from pulmonary artery stenoses may affect outcome and survival after liver transplantation in patients with Alagille syndrome. METHODS AND
RESULTS: Between 1984 and 1997, among 444 pediatric liver transplant recipients, 17 had liver transplantation for Alagille syndrome (mean age 3.5 years, range 1.2-13 years), mainly because of poor quality of life with intractable pruritus, and failure to thrive. All patients had pulmonary artery stenosis. In 10 patients considered to have elevated RV pressure on ECG and/or Doppler-echocardiography, a cardiac catheterization was performed before liver transplantation. Mean RV systolic pressure was 55 mmHg (median 49.5 mmHg, range 35-98 mm Hg), mean RV to left ventricular systolic pressure ratio 0.53 (median 0.53, range 0.29-0.78) with a ratio above 0.5 in 6 patients (median 0.66, range 0.5-0.8). All patients underwent successful liver transplantation. Five patients died 1 to 9 months after transplantation from noncardiac causes. In two of them, cardiac catheterization before transplantation showed a RV to left ventricular pressure ratio of 0.51 in one and 0.37 in the second. In the three others, echocardiography before transplantation estimated RV pressures below 0.5 systemic pressures. At follow-up (median 6 years, range 1.5-15 years), liver tests were normal in all, none complained of pruritus and body weight was normalized in 70%. None of the patients presented cardiac symptoms, arrhythmias, or worsening of their cardiac status.
CONCLUSIONS: Liver transplantation can be performed safely in children with Alagille syndrome, even in the presence of elevated right ventricular pressure.

Entities:  

Mesh:

Year:  2001        PMID: 11477367     DOI: 10.1097/00007890-200107270-00034

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Management of large hepatocellular carcinoma in adult patients with Alagille syndrome: a case report and review of literature.

Authors:  Susan Tsai; Ahmet Gurakar; Robert Anders; Dora Lam-Himlin; John Boitnott; Timothy M Pawlik
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

Review 2.  Multidisciplinary Management of Alagille Syndrome.

Authors:  Jagadeesh Menon; Naresh Shanmugam; Mukul Vij; Ashwin Rammohan; Mohamed Rela
Journal:  J Multidiscip Healthc       Date:  2022-02-23

Review 3.  Pulmonary artery pathologies in Alagille syndrome: a meta-analysis.

Authors:  Shi-Min Yuan
Journal:  Postepy Kardiol Interwencyjnej       Date:  2022-08-19       Impact factor: 1.065

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.